Barclays has appointed Khaled Habayeb as a Managing Director in Healthcare Equity Capital Markets (ECM). Habayeb will be based in New York, and will report to Taylor Wright and Kristin DeClark, Co-Heads of ECM Americas at Barclays. He will partner with Joe Lombardo in leading the further development and execution of the firm’s Healthcare ECM business strategy.
Habayeb joins Barclays with over seventeen years of experience in banking, most recently as a Managing Director in the Global Healthcare Group at Deutsche Bank, where he led biotechnology sector coverage across therapeutic areas and genomics sub-sectors. Prior to joining Deutsche Bank in late 2018, Habayeb was a Managing Director and Head of Healthcare ECM at UBS. In this role he led the origination and execution of public and private equity transactions for healthcare clients, including in the biotechnology, tools & diagnostics, medical technology, healthcare services and information technology sub-sectors. Before joining UBS in February 2015, Habayeb was Head of Investor Relations at Foundation Medicine, Inc. Habayeb started his career at JP Morgan, where he worked for over ten years in senior roles within the Healthcare Equity Capital Markets team.
“Khaled is an outstanding addition to our ECM team and brings with him a wealth of Healthcare specific knowledge,” says Wright. “His long-established industry relationships and his extensive transactional experience will generate great value for our clients.”
“As the Healthcare sector continues to evolve at a rapid pace, our clients more than ever depend on Barclays for sound strategic advice and seamless execution,” adds Rick Landgarten, Global Head of Healthcare & Real Estate Groups. “Khaled will help ensure that we further build on our business strengths and momentum, as we continue to drive ECM mind and market share with our clients.”
